Soleno Therapeutics (SLNO) Operating Margin (QoQ) (2015 - 2026)

Soleno Therapeutics (SLNO) Operating Margin (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,008.00
Dec 31, 2025 966.00
Sep 30, 2025 5,346.00
Jun 30, 2017 -29.63 Mn
Mar 31, 2017 -39,176.00
Dec 31, 2016 47,182.00
Sep 30, 2016 11.42 Mn
Jun 30, 2016 -11.38 Mn
Mar 31, 2016 -4,866.00
Dec 31, 2015 38,363.00
Sep 30, 2015 184,948.00
Jun 30, 2015 788,913.00